Background: We have previously shown that increased resting-state functional magnetic resonance imaging (fMRI)-based functional connectivity (FC) within the frontal resting-state networks in Alzheimer's disease (AD) patients reflects residual, possibly compensatory, function. This suggests that symptomatic treatments should aim to enhance FC specifically in these networks. Methods: 18 patients with probable AD underwent brain MRI and neuropsychological assessment at baseline and after 12 weeks of treatment with donepezil. We tested if changes in cognitive performance after treatment correlated with changes in FC in resting-state networks known to be altered in AD. Results: We found increases in FC in the orbitofrontal network that correlated with cognitive improvement after treatment. The increased FC was greatest in patients who responded most to treatment. Conclusion: This 'proof of concept' study suggests that changes in network-specific FC might be a biomarker of pharmacological intervention efficacy in AD.

Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study / Griffanti, Ludovica; Wilcock, Gordon K.; Voets, Natalie; Bonifacio, Guendalina; Mackay, Clare E.; Jenkinson, Mark; Zamboni, Giovanna. - In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. EXTRA. - ISSN 1664-5464. - 6:3(2016), pp. 518-528. [10.1159/000450546]

Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study

ZAMBONI, Giovanna
2016

Abstract

Background: We have previously shown that increased resting-state functional magnetic resonance imaging (fMRI)-based functional connectivity (FC) within the frontal resting-state networks in Alzheimer's disease (AD) patients reflects residual, possibly compensatory, function. This suggests that symptomatic treatments should aim to enhance FC specifically in these networks. Methods: 18 patients with probable AD underwent brain MRI and neuropsychological assessment at baseline and after 12 weeks of treatment with donepezil. We tested if changes in cognitive performance after treatment correlated with changes in FC in resting-state networks known to be altered in AD. Results: We found increases in FC in the orbitofrontal network that correlated with cognitive improvement after treatment. The increased FC was greatest in patients who responded most to treatment. Conclusion: This 'proof of concept' study suggests that changes in network-specific FC might be a biomarker of pharmacological intervention efficacy in AD.
2016
6
3
518
528
Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study / Griffanti, Ludovica; Wilcock, Gordon K.; Voets, Natalie; Bonifacio, Guendalina; Mackay, Clare E.; Jenkinson, Mark; Zamboni, Giovanna. - In: DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. EXTRA. - ISSN 1664-5464. - 6:3(2016), pp. 518-528. [10.1159/000450546]
Griffanti, Ludovica; Wilcock, Gordon K.; Voets, Natalie; Bonifacio, Guendalina; Mackay, Clare E.; Jenkinson, Mark; Zamboni, Giovanna
File in questo prodotto:
File Dimensione Formato  
450546.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 1.09 MB
Formato Adobe PDF
1.09 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1129117
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 16
social impact